Earnings Report Q3'25 Using Proven, Innovative Adjuvant Technology to Help Protect the World Against Infectious Diseases November 2025 Nasdaq: DVAX Forward-Looking Statements Statements contained in this presentation regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about Dynavax's financial results and market share as of and for the quarter ended September 30, 2025, expectations r ...